GlucoTrack, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
GCTK Nasdaq 3840 glucotrack.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for GlucoTrack, Inc.

Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs - Jan 15th, 2025 1:01 pm
Glucotrack to Present at TechBio Showcase™ 2025 - Jan 7th, 2025 9:05 pm
GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR - Dec 3rd, 2024 1:30 pm
Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt - Nov 14th, 2024 9:30 pm
Glucotrack, Inc. Announces Pricing of $10.0 Million Public Offering - Nov 13th, 2024 2:00 pm
GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE - Oct 22nd, 2024 1:00 pm
GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING - Oct 1st, 2024 1:00 pm
JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS - Sep 3rd, 2024 1:00 pm
GLUCOTRACK ANNOUNCES NEW VICE PRESIDENT OF CLINICAL OPERATIONS - Aug 27th, 2024 1:00 pm
Glucotrack’s Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference - Aug 15th, 2024 1:00 pm
GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE - Aug 5th, 2024 1:00 pm
GLUCOTRACK ANNOUNCES NEW FUNDING FOR DEVELOPMENT OF ITS CONTINUOUS BLOOD GLUCOSE MONITOR - Jul 31st, 2024 8:00 pm
GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORS - Jun 20th, 2024 12:30 pm
GLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY OF ITS EPIDURAL GLUCOSE MONITORING SENSOR - Jun 13th, 2024 1:19 pm
Sidoti Events, LLC's Virtual June Small-Cap Conference - Jun 11th, 2024 2:50 pm
GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCE - Jun 10th, 2024 2:50 pm
GLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR - Jun 5th, 2024 12:30 pm
GLUCOTRACK’S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES SUCCESSFUL 30-DAY SAFETY & PERFORMANCE IN LONG-TERM PRECLINICAL STUDY - May 16th, 2024 12:30 pm
GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT - May 15th, 2024 8:15 pm
GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION - May 2nd, 2024 1:00 pm